GENFIT S.A PE Ratio 2019-2021 | GNFT
Current and historical p/e ratio for GENFIT S.A (GNFT) from 2019 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. GENFIT S.A PE ratio as of October 22, 2021 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
|GENFIT S.A PE Ratio Historical Data
||TTM Net EPS
||Medical - Biomedical and Genetics
Genfit SA is a biopharmaceutical company. It focuses on the discovery and development of therapeutic and diagnostic solutions in metabolic and liver related diseases. The company's lead products include Elafibranor, Nitazoxanide and TGFTX1 which are in clinical stage. Genfit SA is based in Loos, France.